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Alagille syndrome(ALGS) is an autosomal-dominant multisystem disorder affecting 
the liver, heart, face, eyes, skeleton and other organs. It is caused by mutations in 
one of two genes in the Notch signaling pathway, the Jagged1 (JAG1) gene or, in 
rare circumstances, the Notch homolog 2 (NOTCH2) gene. The object of this study is 
to evaluate combined genetic analyses with targeted next-generation sequencing 
(NGS), multiplex ligation probe amplification (MLPA) of JAG1 and microarray 
comparative genomic hybridization (CGH) in subjects with ALGS, incomplete 
clinical features of ALGS and biliary atresia (BA). We recruited subjects from April 
2013 to December 2015. All subjects underwent a targeted NGS analysis, including 
JAG1 and NOTCH2. If no mutations were detected in JAG1 or NOTCH2, or if copy 
number variations were suggested by the NGS analysis, we performed an MLPA 
analysis of JAG1. We also performed a microarray CGH analysis with whole-exon 
deletion detected by the MLPA analysis. Thirty subjects with ALGS, nine with 
incomplete ALGS and 17 with BA were enrolled, and detected pathogenic mutations 
in JAG1 or NOTCH2 in 24/30 subjects with ALGS and in 4/9 subjects with 
incomplete ALGS. No pathogenic mutations were detected in subjects with BA. The 
frequency of JAG1 mutations was as follows: single nucleotide variants (51.9%), 
small insertion or deletion (29.6%) and gross deletion (18.5%). The distribution of 
types of mutations in JAG1 in this study was similar to that reported in a previous 
study, except for gross deletions, including partial-exon deletions and whole-exon 
deletions. Combined genetic analyses achieved efficient diagnostic yields for subjects 
with ALGS and incomplete ALGS. 
